Resverlogix (TSE:RVX) Shares Cross Below 50 Day Moving Average – Should You Sell?

Resverlogix Corp. (TSE:RVX)’s share price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.07 and traded as low as C$0.07. Resverlogix shares last traded at C$0.07, with a volume of 1,000 shares.

Resverlogix Stock Performance

The firm has a fifty day moving average price of C$0.07 and a 200 day moving average price of C$0.06. The company has a market cap of C$18.00 million, a price-to-earnings ratio of -1.30 and a beta of 0.71.

Resverlogix (TSE:RVX) last announced its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported C($0.02) EPS for the quarter. On average, analysts expect that Resverlogix Corp. will post -0.22 EPS for the current fiscal year.

Resverlogix Company Profile

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.